Cohen & Steers (CNS) EVP receives 354-share dividend-equivalent stock grant

Rhea-AI Filing Summary

COHEN & STEERS, INC. Executive Vice President Daniel Noonan reported an acquisition of 354 shares of Common Stock on account of a compensation-related award. The Form 4 identifies this as a grant or award, not an open-market purchase, with a price per share of $0.0000.

Footnotes explain the award represents dividend equivalent restricted stock units tied to the issuer’s first quarter 2026 dividend, credited on unvested restricted stock units granted in June 2024, January 2025 and January 2026. Following the grant, Noonan directly holds 35,274 Common Stock shares and indirectly holds 895 shares through the Daniel A. Noonan Revocable Trust.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Noonan Daniel

Role Executive Vice President

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	354	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 35,274 shares (Direct); Common Stock — 895 shares (Indirect, By the Daniel A. Noonan Revocable Trust)

Footnotes (1)

1. Shares held by the Daniel A. Noonan Revocable Trust, a revocable trust, of which Mr. Noonan and an immediate family member serve as trustees. Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's first quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in June 2024, January 2025 and January 2026.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Noonan Daniel

(Last) (First) (Middle)

1166 AVENUE OF THE AMERICAS

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								895	I	By the Daniel A. Noonan Revocable Trust(1)
Common Stock	03/19/2026		A		354(2)	A	$0	35,274	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares held by the Daniel A. Noonan Revocable Trust, a revocable trust, of which Mr. Noonan and an immediate family member serve as trustees.

2. Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's first quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in June 2024, January 2025 and January 2026.

Remarks:

	/s/ Brian W. Heller, Attorney-in-Fact	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CNS Executive Vice President Daniel Noonan report?

Daniel Noonan reported receiving 354 CNS Common Stock shares as a grant, not a market purchase. The award reflects dividend equivalent restricted stock units credited in connection with the company’s first quarter 2026 dividend on prior unvested restricted stock unit grants.

How many CNS shares does Daniel Noonan hold after this Form 4 filing?

After the reported transactions, Daniel Noonan directly holds 35,274 CNS Common Stock shares and indirectly holds 895 shares. The indirect shares are held through the Daniel A. Noonan Revocable Trust, where he and an immediate family member serve as trustees.

Was the CNS Form 4 transaction an open-market buy or a compensation grant?

The CNS Form 4 shows a compensation-related grant, not an open-market buy. Code “A” identifies it as a grant or award, with 354 shares received at a stated price of $0.0000 per share, linked to dividend equivalent restricted stock units.

What is the source of the 354 CNS shares granted to Daniel Noonan?

The 354 CNS shares stem from dividend equivalent restricted stock units. These units were accrued on Noonan’s unvested restricted stock units that were originally granted in June 2024, January 2025, and January 2026, in connection with the first quarter 2026 dividend.

How are Daniel Noonan’s indirect CNS share holdings structured?

Noonan’s indirect CNS holdings are 895 Common Stock shares held by the Daniel A. Noonan Revocable Trust. According to the footnote, it is a revocable trust where Noonan and an immediate family member act as trustees, reflecting indirect ownership.

Does this CNS Form 4 indicate any derivative securities or option exercises?

This CNS Form 4 does not report any derivative security exercises. The transaction relates to 354 Common Stock shares acquired through dividend equivalent restricted stock units, and the derivative section of the summary shows no remaining derivative positions in this filing.